Moderna (MRNA) News Today $72.89 -0.55 (-0.75%) (As of 09/6/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 Time Period September 7 at 9:25 AM | markets.businessinsider.comINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ModernaSeptember 7 at 7:44 AM | marketbeat.comCandriam S.C.A. Buys 40,007 Shares of Moderna, Inc. (NASDAQ:MRNA)Candriam S.C.A. boosted its stake in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 9.1% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 482,052 shares of the company's stock after acquiring an additional 40,007 shSeptember 7 at 4:31 AM | fool.comIs It Time to Buy August's Worst-Performing Nasdaq Stocks?September 7 at 4:23 AM | msn.comPandemic Darling Moderna Needs a Reality CheckSeptember 6 at 5:45 AM | prnewswire.comMRNA LAWSUIT ALERT: Levi & Korsinsky Notifies Moderna, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineSeptember 5 at 7:59 PM | markets.businessinsider.comROSEN, LEADING TRIAL ATTORNEYS, Encourages Moderna, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRNASeptember 5 at 2:58 PM | finance.yahoo.comModerna mpox mRNA vaccine shows early promise in monkey studySeptember 5 at 1:04 PM | globenewswire.comModerna, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – MRNASeptember 5 at 12:04 PM | globenewswire.comROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Moderna, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRNASeptember 5 at 9:57 AM | msn.comModerna Stock (MRNA) Nears a Support Level, Is It a Buy?September 5 at 7:27 AM | insidertrades.comModerna, Inc. (NASDAQ:MRNA) President Sells $24,482.82 in StockSeptember 5 at 5:45 AM | prnewswire.comModerna, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before October 8, 2024 to Discuss Your Rights - MRNASeptember 4 at 10:54 PM | globenewswire.comModerna, Inc. Shareholders - Robbins LLP Reminds MRNA Stockholders of the Class Action Lawsuit Against the Company – Seek Counsel TodaySeptember 4 at 7:01 PM | marketbeat.comStephen Hoge Sells 318 Shares of Moderna, Inc. (NASDAQ:MRNA) StockModerna, Inc. (NASDAQ:MRNA - Get Free Report) President Stephen Hoge sold 318 shares of Moderna stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $76.99, for a total value of $24,482.82. Following the completion of the transaction, the president now owns 1,443,002 shares of the company's stock, valued at approximately $111,096,723.98. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.September 4 at 4:00 PM | globenewswire.comMRNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Moderna, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!September 4 at 3:01 PM | msn.comModerna's mRNA-based mpox vaccine shows promise in trialsSeptember 4 at 3:01 PM | msn.comModerna’s experimental mpox vaccine reduces severity of disease, early study findsSeptember 4 at 3:01 PM | yahoo.comModerna mRNA mpox vaccine shows promise in animal studySeptember 4 at 3:01 PM | forbes.comModerna’s First mRNA Mpox Vaccine Beats Licensed Rival Shots In Early TestingSeptember 4 at 3:01 PM | usnews.comModerna's mRNA- Based Mpox Vaccine Shows Promise in Monkey TrialSeptember 4 at 7:21 AM | fool.comIs It Time to Buy August's Worst-Performing S&P 500 Stocks?September 4 at 4:03 AM | americanbankingnews.comModerna, Inc. (NASDAQ:MRNA) Receives Consensus Rating of "Hold" from BrokeragesSeptember 3, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Moderna, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRNASeptember 3, 2024 | prnewswire.comShareholders that lost money on Moderna, Inc.(MRNA) Urged to Join Class Action - Contact Levi & Korsinsky to Learn MoreSeptember 2, 2024 | americanbankingnews.comModerna, Inc. (NASDAQ:MRNA) Insider Sells $12,640.86 in StockSeptember 2, 2024 | americanbankingnews.comModerna (NASDAQ:MRNA) versus OKYO Pharma (NASDAQ:OKYO) Head-To-Head SurveySeptember 1, 2024 | globenewswire.comROSEN, GLOBAL INVESTOR COUNSEL, Encourages Moderna, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRNASeptember 1, 2024 | marketbeat.comPrivium Fund Management B.V. Has $2.72 Million Stock Holdings in Moderna, Inc. (NASDAQ:MRNA)Privium Fund Management B.V. cut its stake in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 41.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 23,261 shares of the company's stock after selling 16,600 shares during theSeptember 1, 2024 | stockhouse.comSHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ModernaSeptember 1, 2024 | americanbankingnews.comStephen Hoge Sells 300 Shares of Moderna, Inc. (NASDAQ:MRNA) StockSeptember 1, 2024 | markets.businessinsider.comROSEN, GLOBAL INVESTOR COUNSEL, Encourages Moderna, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRNASeptember 1, 2024 | americanbankingnews.comInsider Selling: Moderna, Inc. (NASDAQ:MRNA) CFO Sells $104,874.19 in StockAugust 31, 2024 | marketbeat.comAvaii Wealth Management LLC Makes New Investment in Moderna, Inc. (NASDAQ:MRNA)Avaii Wealth Management LLC bought a new position in Moderna, Inc. (NASDAQ:MRNA - Free Report) in the 2nd quarter, according to its most recent filing with the SEC. The institutional investor bought 22,336 shares of the company's stock, valued at approximately $2,652,000. Moderna accounts for 1.5August 31, 2024 | insidertrades.comModerna, Inc. (NASDAQ:MRNA) Insider Shannon Thyme Klinger Sells 162 SharesAugust 30, 2024 | prnewswire.comMRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud LawsuitAugust 30, 2024 | stockhouse.comThe Schall Law Firm Urges Moderna Inc. Investors To Take Part In A Securities Fraud SuitAugust 30, 2024 | insidertrades.comModerna, Inc. (NASDAQ:MRNA) CFO Sells $104,874.19 in StockAugust 30, 2024 | msn.comHSBC Upgrades Moderna (MRNA)August 30, 2024 | americanbankingnews.comModerna (NASDAQ:MRNA) Stock Rating Upgraded by HSBCAugust 29, 2024 | marketbeat.comJames M. Mock Sells 1,321 Shares of Moderna, Inc. (NASDAQ:MRNA) StockModerna, Inc. (NASDAQ:MRNA - Get Free Report) CFO James M. Mock sold 1,321 shares of the stock in a transaction dated Wednesday, August 28th. The shares were sold at an average price of $79.39, for a total transaction of $104,874.19. Following the completion of the transaction, the chief financial officer now directly owns 8,600 shares of the company's stock, valued at $682,754. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.August 29, 2024 | msn.comModerna, Inc. (MRNA): Among The Best Medical AI CompaniesAugust 29, 2024 | msn.comModerna And BioNTech Bet On Personalized Cancer Vaccines To Revive Fortunes After Dwindling COVID-19 Vaccine SalesAugust 29, 2024 | globenewswire.comMRNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Moderna, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!August 29, 2024 | americanbankingnews.comModerna (NASDAQ:MRNA) Lifted to Hold at Hsbc Global ResAugust 29, 2024 | marketbeat.comModerna (NASDAQ:MRNA) Upgraded to Hold at Hsbc Global ResHsbc Global Res upgraded shares of Moderna from a "moderate sell" rating to a "hold" rating in a research note on Wednesday.August 29, 2024 | prnewswire.comClass Action Filed Against Moderna, Inc. (MRNA) - October 8, 2024 Deadline to Join - Contact The Gross Law FirmAugust 28, 2024 | globenewswire.comROSEN, NATIONAL TRIAL LAWYERS, Encourages Moderna, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRNAAugust 28, 2024 | globenewswire.comShareholder Rights Law Firm Robbins LLP Urges Moderna, Inc. Stockholders to Seek Counsel for the MRNA Class ActionAugust 28, 2024 | globenewswire.comShareholders that lost money on Moderna, Inc. (MRNA) Urged to Join Class Action – Contact Levi & Korsinsky to Learn MoreAugust 28, 2024 | prnewswire.comMRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit with the Schall Law Firm Get Moderna News Delivered to You Automatically Sign up to receive the latest news and ratings for MRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Kamala’s Dirty Election Move… Revealed (Ad)According to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppet masters are planning this dirty election move… Click here now and learn how to prepare. MRNA Media Mentions By Week MRNA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRNA News Sentiment▼0.240.55▲Average Medical News Sentiment MRNA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRNA Articles This Week▼3521▲MRNA Articles Average Week Get Moderna News Delivered to You Automatically Sign up to receive the latest news and ratings for MRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Biogen News Neurocrine Biosciences News Bio-Techne News Repligen News CRISPR Therapeutics News Denali Therapeutics News GSK News Takeda Pharmaceutical News Teva Pharmaceutical Industries News BioNTech News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MRNA) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moderna, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Moderna With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free mrna Stock Alerts